We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Vienna, Austria

ESTRO 2025

Session

Monday
May 05
15:15 - 16:15
Stolz 1
Lung 2
Fiona McDonald, United Kingdom;
Justyna Kociolek, Portugal
Mini-Orals are presented at one of the sessions scheduled in the two mini-oral theatres. Each author will present a 4-slide PowerPoint orally for 4 minutes, followed by 3 minutes for discussion. Sessions will be recorded and made available via the online platform and mobile app.
Mini-Orals
Clinical
Lung
15:00 - 15:07
Dose-volume predictors of cardiac adverse events after high-dose thoracic radiation therapy for lung cancer: a systematic review and meta-analysis
Laura Saint-Lary, France
E25-2627
15:07 - 15:14
Real-world treatment outcomes comparing once- versus twice-daily thoracic irradiation therapy in limited-stage small cell lung cancer
Jose Belderbos, The Netherlands
E25-2374
15:21 - 15:28
Omitting clinical target volume of primary tumor versus standard irradiation for LS-SCLC: preliminary report of a randomized, non-inferior trial
Shuohan Zheng, China
E25-2521
15:28 - 15:35
Dose-response analysis of esophageal dose surface maps for patients with small-cell lung cancer treated with twice-daily radiotherapy
Hild Milde Bekkevoll, Norway
E25-3623
15:35 - 15:42
A Randomized , Phase II Study of Primary Tumor Radiotherapy for Non-Small Cell lung Cancer with Malignant Pleural Effusion? NCT 03987087?
Qingsong Li, China
E25-700
15:42 - 15:49
Conventional Radiotherapy and Thoracic SABR for Synchronous Oligometastatic NSCLC: Acute Toxicity Findings from the SARON Thoracic Safety Sub-Study
Ragu Ratnakumaran, United Kingdom
E25-2471
15:49 - 15:56
Impact of Estimated Dose of Radiation to Immune Cells (EDRIC) in Locally Advanced NSCLC: Secondary Analysis of the Randomized PET-Plan Trial
Eleni Gkika, Germany
E25-2814